The Impact of Brexit on European Biotech and Biopharma
At the commencement of her national campaign in July 2016, the former UK Prime Minister Theresa May stated, “It is hard to think of an…
What to Expect at AAPS 2020 PharmSci 360
It’s that time of the year again. October 26th marks the beginning of the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 event. This yearly…
Utilizing Bradford Assay for Protein Concentration Calculation
If your goal is to attain swift and simple protein quantification, the Bradford assay is the way to go. Let’s find out more about what…
A Beginner’s Guide to Luciferase Assays
Luciferase is an enzyme used by a variety of organisms for bioluminescence. One of the most common examples of bioluminescence exists in the biology of…
The Difference Between Pharmacokinetics and Pharmacodynamics
In the United States, the safety and efficacy of prescription and over-the-counter drugs are a top priority for our government, medical professionals, and pharmaceutical companies.…
BioAgilytix’s Boston Team Q&A: Meet Benjamin Lamothe, Clinical Research Scientist
The best science demands the best people—and at BioAgilytix’s Boston lab, there’s no shortage of skilled and dedicated scientists. Get to know one of our…
CLIA, COLA & CAP: What’s the Difference?
BioAgilytix’s CLIA Laboratory Director, Natalie Smith, outlines the differences between CLIA, CAP & COLA regulations & accreditations, and what they mean for laboratory testing quality.
Making the Move: A Look into the Career Transition from Pharma/Biotech to CRO
In our recruitment process we are often asked by those coming from pharma & biotech careers, “what’s a day in the life like at a…
Impact of Pre-Existing Immunogenicity Against AAV on Gene Therapy Trials
The concept of using pre-existing immunogenicity as an exclusion criteria for gene therapy clinical trials is changing. BioAgilytix’s Chief Scientific Officer, Dr. Jim McNally, explores…
Behind the Science Perspectives with Dr. Jim McNally, BioAgilytix’s Chief Scientific Officer
We recently sat down with Dr. Jim McNally for a Q&A to hear his "Behind the Science" perspectives on the industry and where he thinks…